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Abstract
Background: The related proteins Boi1 and Boi2, which appear to promote polarized growth in
S. cerevisiae, both contain a PH (pleckstrin homology) and an SH3 (src homology 3) domain.
Previously, we gained evidence that a PH domain-bearing segment of Boi1, which we call Boi1-PH,
is sufficient and necessary for function. In the current study, we investigate the binding of Boi1's PH
domain to the acidic phospholipids PIP2 (phosphatidylinositol-4,5-bisphosphate) and PS
(phosphatidylserine).
Results: Boi1-PH co-sediments with PS vesicles. It does so more readily when these vesicles
contain a small amount of PIP2. Boi1-PH is degraded in yeast extracts in a manner that is stimulated
by PIP2. Amino-acid substitutions that diminish binding to PIP2 and PS impair Boi1 function. Fusion
to a myristoyl group-accepting sequence improves to different degrees the ability of these different
mutant versions of Boi1-PH to function. Boi1 and Boi2 are localized to the periphery of buds during
much of the budding cycle and to necks late in the cell cycle. Amino-acid substitutions that diminish
binding to PIP2 and PS impair localization of Boi1 to the bud, but do not affect the localization of
Boi1 to the neck. Conversely, a mutation in the SH3 domain prevents the localization of Boi1 to
the neck, but does not impair localization to the bud.
Conclusions: Boi1's PH domain binds to acidic phospholipids, and this binding appears to be
important for Boi1 function. The main role of binding to PS may simply be to promote the
association of the PH domain with membrane. The higher-affinity binding to PIP2, which apparently
promotes a conformational change in the PH domain, may play an important additional role. Boi1
and Boi2 are localized to sites of polarized growth. Whereas the SH3 domain is needed for
localization of Boi1 to the neck, the phospholipid-binding portion of the PH domain is important
for localization to the bud.
Background
The Bem1-interacting proteins Boi1 and Boi2 were identi-
fied from screens for proteins that display two-hybrid in-
teraction with the bud-emergence protein Bem1 [1,2], a
protein that is important for the initiation of budding and
that contains two SH3 domains. Boi1 and Boi2 are similar
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in sequence to one another. Each contains an SH3 do-
main; a SAM (sterile alpha motif) domain; a proline-rich
region, which mediates binding to the second SH3 do-
main of Bem1; and a PH domain [1–3]. Figure 1 shows
the relative positions of these sequence features in Boi1.
Deletion of either BOI1 or BOI2 alone has little effect on
growth. However, deletion of both genes together is lethal
(at least in some strains), suggesting that Boi1 and Boi2
perform at least one important, shared function [1,2].
The functions of Boi1/Boi2 appear to be linked to those of
Cdc42 and Rho3, which are Rho-type GTPases that are im-
portant for polarized cell growth [4–9]. Boi1 and Boi2 dis-
play two-hybrid interactions with both wild-type and
mutationally activated Cdc42 but not with a mutant ver-
sion of Cdc42 that is predicted to be impaired in the abil-
ity to bind nucleotide, suggesting that Boi1 and Boi2 may
associate with the GTP-bound ("active") form of Cdc42
[1]. Further evidence that some function of Boi1 is linked
to that of Cdc42 is that overexpression of Boi1 inhibits
bud emergence and that this inhibition can be suppressed
by overexpression of Cdc42 [1,2]. RHO3 can serve as a
multicopy suppressor of the lethality caused by deletion
of BOI1 and BOI2 [1,2]. These findings are consistent with
the possibilities that Boi1 and Boi2 are targets of Cdc42
that promote cell growth in a manner that is regulated by
Rho3.
Support for the view that Boi1 and Boi2 are involved in
polarized growth comes from the analysis of fission yeast
Pob1, which is a homolog of Boi1 and Boi2. In particular,
in S. pombe cells, Pob1 is localized to sites of polarized
growth, loss of Pob1 function leads to a loss of polarized
growth, and overexpression of Pob1 causes cell growth to
become depolarized [10].
The PH domain appears to be a critical feature of Boi1:
mutations in this domain destroy Boi1 function, and
Boi1-PH (see Fig. 1) can substitute in function for Boi1
and Boi2 [1]. In addition, Boi1-PH contains the region of
Boi1 that displays the two-hybrid interaction with Cdc42,
raising the possibility that the PH domain, itself, mediates
or regulates the association with Cdc42 [1].
A generally shared feature of PH domains is the ability to
bind acidic phospholipids, usually one or more derived
from PI (phosphatidylinositol) and, in some cases, also
PS [11,12]. In some proteins, the main role of the binding
of PH domains to phospholipids may simply be to pro-
mote association with membrane (i.e., to serve as a mem-
brane-localization tag) [13,14]. In other proteins, the
binding of PH domains to phospholipids appears to be
important for allosteric or other types of regulation
[15,16].
Given that 1) Boi1 and Boi2 are important proteins whose
functions appear to be linked to those of Cdc42 and
Rho3, 2) the PH domain appears to be of particular im-
portance for Boi1 function, and 3) a general role of PH do-
mains may be to bind acidic phospholipids, we wanted to
know whether the PH domain of Boi1 binds acidic phos-
pholipids and, if it does, whether this binding is impor-
tant for the function and proper localization of Boi1. In
the current study, we investigate these issues as a first step
toward eludicating roles of Boi1's PH domain.
Results
Binding of Boi1-PH to phospholipids
In all binding analyses reported in this study, we used
Boi1-PH (see Fig. 1) rather than full-length Boi1, because
we wanted to focus on interactions mediated by the PH
domain. Also, we needed to have a soluble pool of protein
for vesicle co-sedimentation studies, and while most of
the Boi1-PH was soluble (at least when overexpressed),
virtually none of the full-length Boi1 was soluble (wheth-
er or not overexpressed).
Fortuitously, we discovered that Boi1-PH can be prote-
olyzed in yeast extracts in a manner that is stimulated by
PIP2. Figure 2A shows an example of this phenomenon;
whereas most of the anti-Boi1 immunoreactivity was
present in a single band when Boi1-PH was incubated
with control PS vesicles that lacked PIP2, almost all of the
anti-Boi1 immunoreactivity was present in faster-migrat-
ing bands when Boi1-PH was incubated with PS vesicles
that contained PIP2 (lanes 1 and 5). (In this and all sub-
sequent experiments that use PIP2/PS mixed vesicles, the
mass ratio of PIP2:PS was 1:20.) Less total anti-Boi1 im-
munoreactivity was recovered when Boi1-PH was incubat-
ed with PIP2/PS mixed vesicles than when incubated with
vesicles containing only PS (lanes 1 and 5), suggesting
that the faster-migrating species represent degradation
products of Boi1-PH. Consistent with this view, although
Boi1-PH remained stable when incubated for longer inter-
Figure 1
Positions of sequence features in Boi1 and Boi1-PH.
Shown are the relative positions of the SH3 domain, SAM
domain, proline-rich region, and PH domain. Full-length Boi1
is 980 amino acids long. Boi1-PH is the segment of Boi1 from
amino acid position 734 through 980.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/16
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vals with vesicles that contained only PS, the anti-Boi1 im-
munoreactive bands became fainter and then disappeared
altogether when incubated for longer intervals with PIP2/
PS mixed vesicles (data not shown).
The finding that PIP2 can stimulate degradation of Boi1-
PH suggests that PIP2 may bind to Boi1-PH in a manner
that results in the exposure of a protease-sensitive site. We
do not know the identity of the relevant protease. Howev-
er, we found that the PIP2-stimulated proteolysis of Boi1-
PH is strongly enhanced by Ca++ and is inhibited by EGTA
(data not shown), suggesting that this protease may re-
quire Ca++ for activity.
Next, we asked whether proteolysis of Boi1-PH could also
be stimulated by other inositol-based phospholipids. PI
and PI3P (phosphatidylinositol-3-phosphate), presented
in PS-based vesicles, appeared to stimulate slightly the
proteolysis of Boi1-PH, but did so to a much lesser extent
than did PIP2 (Fig. 2A, lanes 1–3 and 5). In contrast, PI4P
(phosphatidylinositol-4-phosphate)/PS vesicles stimulat-
ed substantial proteolysis of Boi1-PH, although to a lesser
extent than did PIP2/PS vesicles (Fig. 2A, lanes 4 and 5).
These findings indicate that different phosphatidyli-
nositides can stimulate proteolysis of Boi1-PH but differ
greatly in their abilities to do so.
To investigate whether the nature of the bulk lipid in the
vesicles affects the ability of phosphatidylinositides to
stimulate proteolysis of Boi1-PH, we repeated this analy-
sis using the neutral phospholipid PC (phosphatidylcho-
line) instead of PS. Using reaction conditions that were
otherwise the same as those used when PS was the bulk li-
pid, no proteolysis of Boi1-PH was detected in the pres-
ence of any of the phosphatidylinositides except PIP2,
which stimulated only a small amount of proteolysis (Fig.
2B). Thus, PS is much more effective than PC at facilitat-
ing the ability of phosphatidylinositides to stimulate pro-
teolysis of Boi1-PH.
To investigate further whether Boi1-PH binds PIP2, we
used a vesicle co-sedimentation assay. In this analysis, we
asked whether an otherwise soluble fraction of Boi1-PH,
after being incubated with PIP2-bearing vesicles, would
now sediment in conditions (436,000 ×  g for 1 hr) that
cause vesicles to pellet. (To inhibit the proteolysis of Boi1-
PH, we performed this analysis in buffer that lacks Ca++
but that contains EGTA and two other protease inhibitors
that were not present in the proteolysis assay.) First, we
asked whether Boi1-PH could pellet with vesicles that
lacked PIP2. We did not detect any pelleting of Boi1-PH
with PC vesicles (data not shown), but found that Boi1-
PH could pellet with vesicles composed of PS (Fig. 3, top
panel), suggesting that Boi1-PH can bind PS.
Next, we asked whether the inclusion of PIP2 in the PS
vesicles affected the ability of Boi1-PH to pellet. In the
starting buffer conditions (phosphate-buffered saline
without additional salt), a larger percentage of Boi1-PH
pelleted when the vesicles contained PIP2 (Fig. 3, lanes 1
and 2). However, most of the Boi1-PH pelleted whether
or not PIP2 was present. So, to try to accentuate the effects
of PIP2 on Boi1-PH's co-sedimentation with vesicles, we
repeated this analysis using buffer that contained addi-
tional concentrations of KCl. In the presence of 50, 100,
and 200 mM additional KCl, the ratio of Boi1-PH that pel-
leted with respect to that which stayed in the supernatant
was greater when using vesicles that contained PIP2 (Fig.
3, lanes 3–8), suggesting that Boi1-PH has a higher affin-
ity for PIP2 than for PS.
In similar experiments using mixed PIP2/PC vesicles, all of
the Boi1-PH stayed in the soluble fraction (data not
shown), supporting the views that the composition of the
lipid bilayer affects the ability of Boi1-PH to bind PIP2
and that PS promotes this association.
Mutant versions of Boi1-PH that are impaired in the abili-
ty to bind PIP2
To investigate whether binding to PIP2 may be important
for Boi1 function, we sought to make mutant versions of
Boi1-PH that are defective in the ability to bind PIP2. As a
guide for designing such mutants, we used information
about one of the PH domains from pleckstrin. Figure 4
Figure 2
Effects of different phospholipids on the proteolysis
of Boi1-PH. Shown are immunoblots, probed with anti-
Boi1 antibodies, of aliquots from a Boi1-PH-bearing yeast
extract that was incubated, in the presence of 2 mM CaCl2
(to allow proteolysis), with vesicles containing PS (part A) or
PC (part B). The vesicles contained either no additional lipid
(lanes 1) or a 1:20 (mass:mass) ratio (with respect to PS or
PC) of PI (lanes 2), PI3P (lanes 3), PI4P (lanes 4), or PIP2
(lanes 5).BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/16
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shows those positions in the N-terminal PH domain of
pleckstrin that have been implicated, based on NMR anal-
ysis, to contact PIP2[17]. Boi1's PH domain has identical
or similar amino acids at most of the analogous positions
(Fig. 4).
To obtain mutant versions of Boi1 that might be defective
in the ability to bind PIP2, we created three sets of muta-
tions that resulted in amino-acid subsitutions at some of
those positions. We call these sets of substitutions "KK"
(K785E and K786A), "TK" (T793A and K795E), and
"KKTK" (K785E, K786A, T793A, and K795E; a combina-
tion of the KK and TK sets) (Fig. 4).
To investigate whether these substitutions affect the abili-
ty of Boi1-PH to bind PIP2, we first used the proteolysis
assay. We found that, in conditions in which PIP2 stimu-
lated proteolysis of most of the wild-type Boi1-PH, PIP2
did not stimulate the proteolysis of the TK, KK, and KKTK
versions of Boi1-PH (Fig. 5A, lanes 3, 6, 9, and 12), sug-
gesting that all three sets of substitutions may disrupt
binding to PIP2 and/or PS.
To investigate further whether the three sets of substitu-
tions affect the ability of Boi1-PH to bind these lipids, we
used the vesicle co-sedimentation assay. In the presence of
vesicles composed of only PS, an appreciable amount of
Boi1-PH(KK) pelleted (Fig. 5B, second panel, lanes 3 and
4). However, the percentage of Boi1-PH(KK) that pelleted
was less than that for wild-type Boi1-PH (Fig. 5B, top and
second panels, lanes 3 and 4), suggesting that the KK sub-
stitutions reduce somewhat the binding affinity for PS.
The TK substitutions had a more obvious effect: no Boi1-
PH(TK) was seen to pellet with PS vesicles (Fig. 5B, third
panel, lanes 3 and 4), suggesting that the TK substitutions
impaired binding to PS to a greater extent than did the KK
substitutions. As expected, given that the TK substitutions
were sufficient to severely affect pelleting with PS vesicles,
none of the Boi1-PH(KKTK) was seen to co-sediment with
PS vesicles (Fig. 5B, bottom panel, lanes 3 and 4).
Whereas inclusion of PIP2 in the vesicles increased the
amount of wild-type Boi1-PH that co-sedimented, PIP2
did not have an obvious effect on the co-sedimentation
behavior of Boi1-PH(KK) (Fig. 5B, top and second panels,
lanes 3–6), suggesting that the KK substitutions impair
binding to PIP2. In contrast, the TK mutant version of
Boi1-PH appeared to retain a slight ability to pellet with
PIP2/PS vesicles (Fig. 5B, third panel, lanes 3–6).
None of the Boi1-PH(KKTK) was detected in the pellet
fraction even when using vesicles that contained PIP2 (Fig.
5A, bottom panel, lanes 5 and 6), consistent with the view
that the KKTK mutant is more severely impaired in the
ability to bind PIP2 than are the KK and TK mutants.
Exploring the significance of binding to phospholipids
To investigate whether binding to phospholipid may be
important for Boi1 function, we used a red/white, colony-
sectoring assay to test whether the KK, TK, and KKTK mu-
tant versions of Boi1 could substitute in function for wild-
type  BOI1 and BOI2. For this analysis, we used strain
PY967, which lacks the genomic copies of BOI1 and BOI2
and which is kept alive by BOI1-bearing plasmid pPB799.
pPB799 also contains the ADE3 color marker. Cells that
have this plasmid are red, while those that fail to inherit it
are white. PY967 cells form thoroughly red colonies (lack-
ing white sectors), because cells that fail to inherit the
plasmid lack BOI1 and so do not propagate. However,
when transformed with a second plasmid that can substi-
tute in function for BOI1, PY967 cells that fail to inherit
pPB799 are still viable and so give rise to white sectors.
To test the different versions of BOI1 for function, we in-
troduced them on plasmids into strain PY967, at both 23
and 30°C, and then scored the degree of sectoring of the
resultant transformant colonies. For each plasmid tested,
approximately 200 colonies from each transformation
plate were analyzed at each temperature. As negative and
positive controls for sectoring, we used an empty plasmid
and one that contains wild-type BOI1, respectively. As in-
dicated in Figure 6, the empty plasmid (-) gave no sector-
ing colonies, indicating that the level of background
sectoring in this assay is low. The plasmid that contains
wild-type BOI1 gave a range of sectoring abilities, with 71
Figure 3
Co-sedimentation of Boi1-PH with vesicles. The two
panels show immunoblots, probed with anti-Boi1 antibodies,
of supernatant (S) and pellet (P) fractions resulting from cen-
trifugation of a mixture of Boi1-PH and vesicles composed
solely of PS (top panel) or composed of a 1:20 (mass:mass)
ratio of PIP2 and PS (bottom panel). For this analysis, prior to
centrifugation, aliquots of a cytosolic preparation of yeast
extract that contained Boi1-PH were incubated with vesicles
in PBS buffer that had the following additional concentrations
of KCl: 0 (lanes 1 and 2), 50 (lanes 3 and 4), 100 (lanes 5 and
6), and 200 mM (lanes 7 and 8).BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/16
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and 79% of the colonies showing a moderate or heavy de-
gree of sectoring at 23 and 30°C, respectively (Fig. 6).
At both temperatures, the TK mutant version of Boi1 al-
lowed a substantial fraction of colonies to show either
moderate or heavy sectoring (Fig. 6), suggesting that the
TK mutant is able to provide whatever vital function nor-
mally is provided by Boi1/Boi2. However, this version of
Boi1 appeared to function less efficiently than did wild-
type Boi1: at 23°C, the percentage of colonies that showed
either moderate or heavy sectoring with Boi1(TK) was
only 29%, and, at 30°C, the percentage of colonies that
showed moderate or heavy sectoring with Boi1(TK) was
only 10%.
At each temperature, almost every one of the colonies of
cells that contained either the KK or KKTK mutant ver-
sions of Boi1 showed no sectoring (Fig. 6), suggesting that
these mutant versions of Boi1 provide little or no func-
tion.
To investigate whether the diminished amount of sector-
ing allowed by the different mutant versions of Boi1
might be due to effects of the amino-acid substitutions on
the concentration of Boi1 (e.g., by decreasing the stability
of Boi1), we used immunoblotting to compare the con-
centrations of the mutant proteins to that of wild-type
Boi1. This analysis was done using a genomically boi1
BOI2 strain, so that the only version of Boi1 present was
the one expressed from a plasmid. As shown in Figure 7A,
each of the mutant versions of Boi1 is present at a concen-
tration similar to or higher than that of wild-type Boi1,
suggesting that the reduced functions of the mutant ver-
sions of Boi1 are not likely to be due to effects on their
concentrations.
One potential role of the binding of Boi1 to phospholipid
is simply to target Boi1 to the plasma membrane. If this
were the only role for such binding, then attachment to a
membrane-localization tag might be able to restore func-
tion to versions of Boi1 that are impaired in the ability to
bind phospholipid. One type of membrane-localization
tag is the myristoyl group, which is attached to the glycine
residue of proteins, such as S. cerevisiae Gpa1 (the α  subu-
nit of the pheromone-responsive G protein) [18], that
contain at their N-termini the sequence MGXXXS/T
(where "X" can be any amino acid) [19]. Thus, we investi-
gated whether fusion to the sequence MGCTVS, which is
present at the N-terminus of Gpa1 and which we will
henceforth refer to as "Myr", could restore function to the
mutant versions of Boi1 that are impaired in the ability to
bind phospholipid.
At the time that we initiated this analysis, the only lipid-
binding-impaired version of Boi1 that we had generated
so far was the KK mutant. In preliminary analyses, we
found that Myr did not improve the ability of full-length
Boi1(KK) to promote sectoring, but that it did improve
the ability of the KK version of Boi1-PH to promote sec-
toring (data not shown). Therefore, in subsequent tests to
ask whether Myr could restore function to mutant ver-
sions of Boi1 that are impaired in the ability to bind lipid,
we used specifically the Boi1-PH segment of Boi1 rather
than full-length Boi1.
First, we checked to see whether Myr had any inhibitory
effects on the function of wild-type Boi1-PH. Myr-
Boi1(PH) allowed a degree of sectoring similar to that for
Boi1-PH without the tag (Fig. 6), suggesting that Myr does
not impair the function of Boi1-PH.
Next, we asked whether Myr could improve the ability of
the different mutant versions of Boi1-PH to function. At
23°C, 25% of colonies containing Boi1-PH(TK) without
the tag showed moderate or heavy sectoring. This value
rose to 81% when using the Myr-tagged version of Boi1-
PH(TK) (Fig. 6), suggesting that Myr improves the ability
of the TK mutant version of Boi1-PH to function. At 30°C,
the effect of Myr was even more striking: without the tag,
only 1% of the Boi1-PH(TK) colonies showed any degree
of sectoring; however, with the tag, 90% of the colonies
showed moderate or heavy sectoring (Fig. 6).
Myr also greatly improved the ability of the KK mutant
version of Boi1-PH to cause sectoring: Myr-Boi1-PH(KK)
allowed 59% moderate or heavy sectoring at 23°C and al-
lowed 28% moderate or heavy sectoring at 30°C, com-
pared to there being no sectoring at either temperature
without Myr (Fig. 6). At 23°C, Myr also improved the
function of the KKTK (the most severe) mutant version of
Boi1-PH: at this temperature, whereas Boi1-PH(KKTK)
Figure 4
Sequences from a PH domain of pleckstrin and from
different versions of Boi1. Asterisks indicate those posi-
tions in a segment of pleckstrin's N-terminal PH domain that
are implicated in binding to PIP2[17]. Of these positions,
those that have the same amino acid at the corresponding
position in Boi1 are indicated with dark shading, and those
that contain a similar amino acid are indicated with light shad-
ing. The sequences of the KK, TK, and KKTK mutant ver-
sions of Boi1 are represented by indicating only those amino
acids in the mutants that are different from those in the cor-
responding positions of the wild-type protein.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/16
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without Myr did not allow any sectoring, Myr-Boi1-
PH(KKTK) allowed 17% of the colonies to show moder-
ate or heavy sectoring (Fig. 6). In constrast, when tested at
30°C, Myr did not affect significantly the amount of sec-
toring allowed by Boi1-PH(KKTK): 98% of the colonies of
cells containing Myr-Boi1-PH(KKTK) were non-sectoring
at this temperature (Fig. 6).
It is unlikely that the mechanism by which Myr improves
the function of the different mutant versions of Boi1-PH
is by increasing their stability, because the presence of Myr
did not have an obvious effect on the relative concentra-
tions of the different versions of Boi1-PH (Fig. 7B).
Localization of wild-type and mutant versions of Boi1 and 
Boi2
To investigate whether binding to phospholipid may be
important for proper localization of Boi1, we used GFP
(green fluorescent protein) fusions to identify first the pat-
terns of localization of wild-type Boi1 and Boi2 and then
those of the mutant versions of Boi1 that are impaired in
the ability to bind phospholipid. The micrographs in Fig-
ure 8 show examples of the different patterns of localiza-
tion observed for wild-type Boi1-GFP. In unbudded cells,
Boi1-GFP was seen to be concentrated in a single spot at
the cell cortex ("polar" pattern) in 70% of the cells (Fig.
8A). In small-budded cells, Boi1-GFP was concentrated in
the bud in 89% of the cells (Fig. 8B). In cells containing
large buds, Boi1-GFP was concentrated in the bud in 50%
of the cells and was concentrated at the neck in 31% of the
cells (Fig. 8C). Boi2-GFP showed distributions of localiza-
tion patterns generally similar to those for Boi1-GFP (Fig.
8A,8B,8C). Thus, Boi1-GFP and Boi2-GFP both appear to
be localized to sites of polarized growth throughout the
cell cycle.
The KK, TK, and KKTK versions of Boi1-GFP all showed a
polar pattern of localization in approximately half of the
unbudded cells (Fig. 8A), suggesting that binding to phos-
pholipid is not critical for this pattern of localization. In
small-budded cells, the KK, TK, and KKTK mutant pro-
teins showed localization to the bud in only 18, 21, and
27% of the cells, respectively (compared to in 89% of the
cells for wild-type Boi1-GFP) (Fig. 8B). Thus, although the
KK, TK, and KKTK mutant proteins all were able to local-
ize to the bud in small-budded cells, they were localized
and/or retained there less efficiently than was wild-type
Boi1-GFP.
A more striking effect of the KK, TK, and KKTK substitu-
tions on the localization of Boi1-GFP was seen in cells
that contained large buds: Boi1-TK-GFP was concentrated
in the bud in only 4% of large-budded cells, and Boi1-KK-
GFP and Boi1-KKTK-GFP were concentrated in the bud in
less than 1% of such cells (Fig. 8C). None of the sets of
substitutions had an obvious effect on localization to the
neck, however (Fig. 8C). These findings suggest that, in
large-budded cells, binding to phospholipid may be im-
portant for the localization of Boi1 to the bud but not for
localization to the neck.
Although our studies focus on roles of Boi1's PH domain,
we were also curious to know which other portions of
Boi1 contribute to its proper patterns of localization. In
particular, we wished to know whether either the SH3 do-
main or the proline-rich (Bem1-binding) region of Boi1 is
Figure 5
Effects of the KK, TK, and KKTK substitutions on the
association of Boi-PH with phospholipids. A). Shown
are immunoblots, probed with anti-Boi1 antibodies, of aliq-
uots from yeast cytosolic extracts containing either wild-type
or mutant versions of Boi1-PH, after incubation with either
no vesicles (lanes 1, 4, 7, and 10), vesicles containing only PS
(lanes 2, 5, 8, and 11), or vesicles composed of a 1:20
(mass:mass) mixture of PIP2 and PS (lanes 3, 6, 9, and 12). B).
The four panels show immunoblots, probed with anti-Boi1
antibodies, of supernatant (S) and pellet (P) fractions, result-
ing after centrifugation, of yeast cytosolic extracts containing
either wild-type Boi1-PH (top panel), Boi1-PH(KK) (second
panel), Boi1-PH(TK) (third panel), or Boi1-PH(KKTK) (bot-
tom panel), with either no vesicles (lanes 1 and 2), vesicles
composed only of PS (lanes 3 and 4), or vesicles composed of
a 1:20 (mass:mass) mixture of PIP2 and PS (lanes 5 and 6).BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/16
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Figure 6
Colony-sectoring analysis to test the ability of different mutant versions of Boi1 and Boi1-PH to substitute in
function for wild-type Boi1 and Boi2. Values are percentages of colonies that displayed each of the different degrees of
sectoring: "none" = no sectoring (i.e., thoroughly red colony), "poor" = one or a few white sectors in an otherwise thoroughly
red colony, "moderate" = more than a few white sectors, but where not more than approximately half of the colony contains
sectors, and "heavy" = most or all of the colony contains white sectors. The circles illustrate these categories of sectoring, with
black representing the red parts of colonies. In this analysis, boi1 boi2 strain PY967, which contains wild-type BOI1 and the
color marker ADE3 on one plasmid (pPB799), was transformed with a second plasmid containing the indicated construct that
was being tested for function. Transformation plates were incubated at 23 or 30°C, as indicated. The different sets of amino-
acid substitutions are indicated in parentheses. "Boi1" = full-length Boi1; "PH" = Boi1-PH; and "Myr-" = fusion to the myristoyl
group-accepting sequence MGCTVS. The constructs were encoded by the following plasmids: - (pPB1306), Boi1 (pPB2003),
Boi1(TK) (pPB2008), Boi1(KK) (pPB2002), Boi1(KKTK) (pPB1671), PH (pPB1695), Myr-PH (pPB1498), PH(TK) (pPB1669),
Myr-PH(TK) (pPB1667), PH(KK) (pPB1697), Myr-PH(KK) (pPB1500), PH(KKTK) (pPB1757), and Myr-PH(KKTK) (pPB1661).BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/16
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important for any pattern of localization. To address this
issue, we used the following mutant versions of Boi1: the
"S" mutant, which contains a Lys residue in place of a Trp
residue at a highly conserved position in the SH3 domain;
the "P" mutant, in which seven of the nine Pro residues in
the Pro-rich region are replaced with Ala residues (a ver-
sion of Boi1 that does not bind Bem1); and the "SP" mu-
tant, which contains both the "S" and "P" changes [1].
The most striking effect of the SH3-domain mutation was
on the localization of Boi1-GFP to necks: we never saw
Boi1-S-GFP localized to necks (Fig. 8C), suggesting that
the SH3 domain is required for such localization. In con-
strast, the SH3-domain mutation had no obvious effect
on the localization of Boi1-GFP to the bud in either small-
or large-budded cells (Figs. 8B and 8C). However, this
mutation increased the frequency of localization to the
periphery of large-budded cells, and it did so to a degree
that approximated that to which it caused a decrease in
the frequency of localization to the neck: in large-budded
cells, whereas wild-type Boi1-GFP was localized to the pe-
riphery of the mother part of the cell in only 3% of the
cells and to the neck in 31% of the cells, Boi1-S-GFP was
localized to the periphery of the mother in 22% of the
cells (and was never localized to the neck). These findings
raise the possibility that failure to localize to the neck in-
creases the likelihood that Boi1 will adopt or retain local-
ization at the periphery of the mother part of the cell.
Another apparent effect of the SH3-domain mutation on
the localization of Boi1-GFP was seen in unbudded cells,
in which the percentage of cells that showed a polar pat-
tern of localization for Boi1-S-GFP (24%) was lower than
for wild-type Boi1-GFP (70%), and in which Boi1-S-GFP
gave a higher percentage of cells that showed the diffuse
pattern (62%) compared to that given by wild-type Boi1-
GFP (24%) (Fig. 8A). These findings raise the possibility
that one way in which Boi1-GFP acquires a polar distribu-
tion in unbudded cells involves prior localization to the
neck, via the SH3 domain.
In all classes of cells, the distributions of localization pat-
terns for Boi1-P-GFP were not notably different from
those for wild-type Boi1-GFP, and the distributions of lo-
calization patterns for Boi1-S-P-GFP were not notably dif-
ferent from those for Boi1-S-GFP (Figs. 8A,8B,8C),
suggesting that the proline-rich region is not important
for any of the observed patterns of localization of Boi1-
GFP.
Discussion
Binding to phospholipids
Boi1-PH co-sediments with PS vesicles, suggesting that
Boi1's PH domain can bind PS. Boi1-PH co-sediments
more readily when such vesicles contain a small percent-
age (5%) of PIP2, suggesting that Boi1-PH also binds PIP2
and that it does so with higher affinity than it binds PS.
Given that PIP2 and PS are negatively charged (with PIP2
being more negatively charged than PS), a model to ac-
count for these binding behaviors is that Boi1's PH do-
main binds in a non-specific manner to negatively
charged surfaces. The ability to bind different acidic phos-
pholipids appears to be a fairly common attribute of PH
domains [11,12]. For example, five out of ten PH domains
in one study were judged to bind to PS with affinity simi-
lar to that for PIP2 and other inositol-based phospholip-
ids, suggesting that many PH domains bind
promiscuously to negatively charged phospholipids [11].
Findings from protease-sensitivity analyses suggest that
Boi1-PH binds in a different manner to PIP2 than to PS,
however. Specifically, proteolysis of Boi1-PH was stimu-
lated by PIP2/PS mixed vesicles but not by vesicles that
contained only PS. For the following reasons, we think
that the inability of PS, by itself, to stimulate the proteol-
ysis of PIP2 is not due to an inability of PS to bind to Boi1-
PH. First, the ability of PIP2 to stimulate proteolysis of
Boi1-PH was greatly enhanced when using PS (rather than
PC) as the bulk lipid in the vesicles, suggesting that PS
binds to Boi1-PH in this analysis. Second, the proteolysis
analysis was conducted in conditions that were very simi-
Figure 7
Relative concentrations of different versions of Boi1
and Boi1-PH in yeast extracts. Shown are immunoblots,
probed with anti-Boi1 antibodies. A). Extracts were from
boi1 strain Y1284 expressing the following versions of Boi1
from the indicated plasmids: lane 1 = no Boi1 (pPB1306); lane
2 = w.t. Boi1 (pPB2003), lane 3 = Boi1(KK) (pPB2002), lane 4
= Boi1(TK) (pPB2008), and lane 5 = Boi1(KKTK) (pPB1671).
B). Extracts were from strain PY967 expressing the following
versions of Boi1-PH from the indicated plasmids: lane 1 = no
Boi1-PH (pPB1306), lane 2 = Boi1-PH (pPB1695), lane 3 =
Myr-Boi1-PH (pPB1498), lane 4 = Boi1-PH(KK) (pPB1697),
lane 5 = Myr-Boi1-PH(KK) (pPB1500), lane 6 = Boi1-PH(TK)
(pPB1669), lane 7 = Myr-Boi1-PH(TK) (pPB1667), lane 8 =
Boi1-PH(KKTK) (pPB1757), and lane 9 = Myr-Boi1-
PH(KKTK) (pPB1661).BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/16
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Figure 8
Localization patterns of GFP fusions to different versions of Boi1 and to wild-type Boi2. Parts A-C show analyses
for unbudded, small-budded, and large-budded cells, respectively. Micrographs are examples of different patterns of localization
of Boi1-GFP. Bars indicate percentages of cells that displayed each of these patterns. In Part C, "peripheral" means localization
around the periphery of the mother part of the cell. GFP fusions to the different versions of Boi1 are encoded by the following
plasmids: W.T. (wild-type) (pPB1307), KK (pPB1347), TK (pPB2007), KKTK (pPB1689), S (pPB1392), P (pPB1394), and SP
(pPB1396). Boi2-GFP ("Boi2") was encoded by plasmid pPB1303.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/16
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lar to those used in the vesicle co-sedimentation analysis,
in which Boi1-PH was found to bind readily to PS. These
findings suggest that, in conditions in which both PS and
PIP2 bind to Boi1-PH, only PIP2 binds in a manner that
triggers the exposure of a protease-sensitive site.
PIP2 was not the only phosphatidylinositide that could
stimulate proteolysis of Boi1-PH; PI4P also did so, al-
though less effectively than did PIP2. In contrast, PI3P and
PI were comparatively ineffective at stimulating proteoly-
sis. The large difference in the ability of PI4P versus PI3P
to stimulate proteolysis supports the view that Boi1's PH
domain can discriminate between different phosphorylat-
ed versions of PI in some manner that involves more than
simply recognizing net charge.
Residues implicated in binding to phospholipid
The KK, TK, and KKTK mutant versions of Boi1-PH con-
tain substitutions at positions in the PH domain that were
predicted to be involved in binding PIP2. PIP2/PS vesicles
did not stimulate the proteolysis of any of these mutant
versions of Boi1-PH, suggesting that each mutant is in-
deed impaired in the ability to associate with PIP2 and/or
PS.
Vesicle co-sedimentation analyses also suggest that each
mutant version of Boi1-PH is impaired in the ability to
bind PIP2/PS vesicles. However, these analyses suggest
that the KK substitutions may impair binding in a differ-
ent manner than do the TK substitutions. In particular, the
co-sedimentation analyses suggest that the TK mutant
may be severely impaired in the ability to bind acidic
phospholipids generally. In contrast, the KK mutant ap-
pears to be impaired more in the ability to recognize spe-
cifically PIP2 than in the ability to bind non-specifically to
acidic phospholipids.
Significance of binding to phospholipids
Based on colony-sectoring analyses, the KK, TK, and KKTK
mutant versions of Boi1 are all impaired in function. The
KK (as well as the KKTK) version of Boi1 appeared to be
completely non-functional, pointing to the possibility
that binding specifically to PIP2 (as opposed to binding to
acidic phospholipids generally) may be critical for Boi1
function.
Fusion to a myristoyl group-accepting sequence appeared
to completely restore function to Boi1-PH(TK), consistent
with the possibility that the TK substitutions may affect
primarily association with membrane. The myristoyl
group-accepting sequence did not completely restore
function to the KK and KKTK versions of Boi1-PH, howev-
er, raising the possibility that, rather than simply promot-
ing general association with membrane, one role of
binding to PIP2 may be to regulate some other behavior
of Boi1 (e.g., the binding of Boi1 to some other protein at
the plasma membrane).
If specific binding to PIP2 (and/or to some other phos-
phatidylinositide, such as PI4P) is critical for Boi1 func-
tion, then how could fusion to a myristoyl group-
accepting sequence (i.e., to a membrane-localization tag)
improve the function of mutant versions of Boi1-PH that
are impaired in the ability to bind PIP2? One possibility is
that each of these mutant versions of Boi1 retains at least
a slight affinity for PIP2 and that the myristoyl group caus-
es these mutant PH domains to be apposed close enough
to the lipid bilayer to enable the residual PIP2-binding ac-
tivity to now be sufficient for binding to PIP2. We specu-
late that, just as binding to PS may serve to position the
PH domain of wild-type Boi1 near the plasma membrane
in a manner that facilitates binding to PIP2, the myristoyl
group may help to situate the PH domain of the mutant
versions of Boi1-PH at the plasma membrane in a manner
that facilitates binding to PIP2.
Although the myristoyl group-accepting sequence im-
proved the ability of the KK mutant version of Boi1-PH to
function, it failed to improve the function of the corre-
sponding mutant version (KK) of full-length Boi1. This
finding is consistent with the possibility that the ability of
the myristoyl group to improve function to a version of
Boi1 that is impaired in the ability to bind phospholipids
may depend on the myristoyl group being near enough to
the PH domain to be able to promote a close association
with membrane of specifically the PH domain portion of
the protein.
Localization of Boi1
A behavior of Boi1 that is affected by mutations that im-
pair binding to phospholipids is the localization of Boi1
to buds. These mutant versions of Boi1 still localize to
mother/bud necks, however. In contrast, a mutation in
the SH3 domain prevents Boi1 from localizing to necks,
but it does not diminish the ability of Boi1 to localize to
buds. These findings suggest that binding to phospholip-
ids may promote the localization of Boi1 to (and/or the
retention of Boi1 at) the bud, but that this binding is not
important for the localization of Boi1 to the neck.
How might binding to phospholipids promote localiza-
tion of Boi1 to buds? One possibility is that the relevant
phospholipid(s) (e.g., PIP2) is itself concentrated in buds.
Another possibility is that the binding to phospholipid
promotes the binding of Boi1 to some other protein that
is itself localized to buds. Other than the unidentified pro-
tease that acts on Boi1 in yeast extracts, the only proteins
that we have evidence for binding to Boi1 are Bem1 and
Cdc42, both of which show localization patterns similar
to those for Boi1 ([20,21], and our unpublished data).BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/16
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Amino-acid substitutions in the proline-rich stretch of
Boi1 that destroy binding to Bem1 do not affect the local-
ization of Boi1, suggesting that binding to Bem1 is not
necessary for any pattern of localization of Boi1.
The situation with respect to Cdc42 is less clear. We have
not yet generated mutations in BOI1 that would allow us
to probe the role of Boi1's interaction specifically with
Cdc42. However, we have observed that the two-hybrid
interaction between Boi1-PH and Cdc42 is not reduced by
substitutions (i.e., KK, TK, and KKTK) that impair binding
to phospholipids. These findings suggest that binding to
phospholipid is not necessary for the interaction between
Boi1 and Cdc42, and so place in doubt the possibility that
the mechanism by which binding to phospholipid pro-
motes localization of Boi1 to buds is by positively regulat-
ing the binding of Boi1 to Cdc42. We note, however, that
these two-hybrid analyses may be quite limited in terms
of what they can reveal about interactions between Boi1
and Cdc42 that might normally occur at the plasma mem-
brane (or at other membranes), because 1) the two-hybrid
assay monitors only those interactions that are occurring
in the nucleus and 2) in these two-hybrid analyses, we
used only versions of Cdc42 that lack a site of isoprenyla-
tion (because we were unable to detect two-hybrid inter-
actions between Boi1 and versions of Cdc42 that retain
that site). Thus, it is still possible that at the plasma mem-
brane, binding to one or more types of phospholipid in-
fluences Boi1's ability to associate with Cdc42.
Alternatively, phospholipids might regulate the binding
of Boi1 to some other, as-yet unidentified binding partner
of Boi1. To us, an important breakthrough toward eluci-
dating the role of the binding of any phospholipid to Boi1
would be the identification of a protein whose binding to
Boi1 is regulated by that phospholipid.
Conclusions
From vesicle co-sedimentation and proteolysis-stimula-
tion analyses, we gained evidence that the PH domain of
Boi1 binds with higher affinity to PIP2 than to PS and that
binding to PIP2 is facilitated by PS and promotes a confor-
mational change in Boi1. Amino-acid substitutions that
diminish binding to PS and PIP2 impair Boi1 function,
and fusion to a myristoyl group-accepting sequence im-
proves the ability of these mutant versions of Boi1-PH to
function, suggesting that binding to phospholipids is im-
portant for Boi1 action. Based on the differing extents to
which the myristoyl group-accepting sequence improved
the ability of the different mutant versions of Boi1-PH to
function, we propose that the main role of binding to PS
is to promote association with membrane and that bind-
ing to PIP2 plays some additional important role. Boi1
and Boi2 are localized to sites of polarized growth, con-
sistent with the view that they are involved in polarized
growth. Whereas the SH3 domain is needed for localiza-
tion of Boi1 to the neck, the phospholipid-binding por-
tion of the PH domain is important for localization to the
bud.
Materials and Methods
Materials
The plasmids used in this study are described in Addition-
al file 1: Plasmids and phage . The yeast strains used are
Y312 (MATα  ura3 leu2 his3 Gal+), Y1284
(MATaboi1::LEU2 ura3 leu2 his3 trp1 met14 Gal+), Y1300
(MATa/MATα  ura3/ura3 leu2/leu2 his3/his3 trp1/trp1
met14/met14 Gal+), and PY967 (MATa/Matα  boi1::LEU2/
boi1::LEU2 boi2::LEU2/boi2::LEU2 ura3/ura3 leu2/leu2
trp1/trp1 ade2/ade2 ade3/ade3 bearing plasmid pPB799).
SC medium is 1.7 g/l yeast nitrogen base without amino
acids and ammonium sulfate, 5 g/l ammonium sulfate, 20
g/l glucose, 20 mg/l uracil, 20 mg/l adenine, 80 mg/l L-
leucine, 20 mg/l L-histidine, 40 mg/l L-tryptophan, 20
mg/l L-methionine, and 30 mg/l L-lysine. SC-Leu, SC-Ura,
and SC-Ura-Leu are SC without leucine, uracil, and both
leucine and uracil, respectively. Sgal-Leu is SC-Leu with 20
g/l galactose plus 20 g/l raffinose instead of glucose.
PBS (phosphate-buffered saline, pH 7.0) is 1.42 g/l
Na2PO4, 245 mg/l KH2PO4, 8 g/l NaCl, and 0.2 g/l KCl.
Protease inhibitors are 40 µg/ml bestatin, 0.7 µg/ml pep-
statin A, 1 mM PMSF, 50 µM leupeptin, 1 mM benzami-
dine, and 1 mM EGTA. 2×  SDS sample buffer is 2%
sodium dodecyl sulfate, 50 mM Tris (pH6.8), 6 M urea,
and bromophenol blue.
Phosphatidylcholine, phosphatidylinositol, and phos-
phatidylserine were from Avanti Polar Lipids (Alabaster,
AL); phosphatidylinositol-4,5-bisphosphate and phos-
phatidylinositol-4-phosphate were from Calbiochem
(San Diego, CA); and phosphatidylinositol-3-phosphate
was from Matreya, Inc. (Pleasant Gap, PA).
AP-PH is affinity-purified anti-Boi1 antibody [1]. AP-101
is affinity-purified anti-Boi1 antibody that was generated
in the same manner as AP-PH, except that it came from
the serum of a different rabbit. Both types of antibody
were affinity purified [22] using a 6× His fusion to the C-
terminal 194 amino acids of Boi1 (the same fusion that
was used as immunogen) [1]. Immobilon P membrane
was from Millipore, Inc. (Bedford, MA). ECL reagents
were from Amersham Pharmacia Biotech, Inc. (Piscata-
way, NJ).
Generation of lipid vesicles
PC and PS were stored dissolved in chloroform at concen-
trations of 20 and 10 mg/ml, respectively. Inositol-based
phospholipids were stored at 1 mg/ml dissolved in a 1:1
mixture of chloroform:methanol. Lipids (pure or mix-BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/16
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tures) were dried down from these solutions under a
stream of nitrogen gas. Bath-type sonication was then
used to generate suspensions of vesicles of these lipids in
PBS.
Proteolysis assay
The wild-type, KK, TK, and KKTK versions of Boi1-PH
were expressed in yeast strain Y312 under the control of
the GAL10 promoter from plasmids pPB900, pPB1308,
pPB1699, and pPB1755, respectively. Cultures were
grown to an O.D.600 of 0.8 in 250 mls of SC-Leu, pelleted,
suspended in 250 mls of Sgal-Leu, and incubated at 30°C
for 16 hours. The following procedures were then per-
formed at 4°C. Cells were pelleted, and the pellets were
rinsed with PBS containing all of the protease inhibitors
except leupeptin, benzamidine, and EGTA. Cells were sus-
pended in PBS containing the same protease inhibitors
and were then lysed using a French press. Large pieces of
cellular debris were removed by centrifugation at 12,000
×  g for 10 min in a Sorval SS34 rotor. Soluble fractions
were then generated by centrifugation of lysates at
541,000 ×  g for 1 hr in a TLA 100.4 rotor in an Optima
TLX ultracentrifuge (Beckman, Palo Alto, CA). To the cy-
tosolic fractions (supernatants), glycerol was added to a fi-
nal concentration of 40%. These fractions were stored at -
20°C and used within one month. 15 µl of 1 mg/ml lipid
vesicle/PBS suspension was mixed with 15 µl of cytosol. 5
mM DTT was included to inactivate any residual PMSF,
and then 2 mM CaCl2 was added to allow proteolysis of
Boi1-PH. Reaction mixtures were then transferred imme-
diately to a 30°C water bath, and proteolysis was inhibit-
ed 5 min later by addition of an equal volume of 2×  SDS
sample buffer containing 2 mM EGTA. Proteins were sep-
arated by SDS-PAGE through a 12% gel, and then proteins
were transferred electrophoretically to Immobilon P
membrane. Blots were probed with anti-Boi1 antibody
AP-PH. Antibody-bound protein bands were detected on
X-ray film using ECL. Each of the proteolysis experiments
was performed at least three times, with similar results.
Vesicle co-sedimentation assay
Yeast cytosol (from 541,000 ×  g spins) containing wild-
type and mutant versions of Boi1-PH were prepared and
stored as described for the proteolysis assay, except that
the protease inhibitors leupeptin, benzamidine, and
EGTA were included. 15 µl of 1 mg/ml lipid vesicle/PBS
suspensions were mixed with 15 µl of cytosol. 30 µl of
PBS, with or without additional KCl, was then added to
each mixture to reduce the concentration of glycerol to ap-
proximately 10%. For the experiment shown in Fig. 3, the
concentrations of additional KCl in the final reaction mix-
ture are indicated. For the experiment shown in Fig. 5B,
no additional KCl was present. Mixtures were then centri-
fuged immediately at 436,000 ×  g for 1 hr in a TLA100 ro-
tor. Supernatants were combined 1:1 with 2×  SDS sample
buffer, and pellets were dissolved in 2×  SDS sample buff-
er. Equal proportions of each fraction were subjected to
SDS-PAGE through a 12% gel, proteins were transblotted
Immobilon P membrane, blots were probed with anti-
body AP-PH, and bound antibodies were detected by ECL.
Each of the vesicle co-sedimentation experiments was per-
formed at least three times, with similar results.
Colony-sectoring assay
Plasmids were introduced into strain PY967 using the lith-
ium thiocyanate procedure [23], and transformants were
selected on SC-Ura. Concentrations of plasmid DNAs
were adjusted so that they would give approximately 400
colonies per petri plate. Transformation plates were incu-
bated at either 23 or 30°C for 4–5 days and then stored at
4°C for one week to allow further development of the red
color. To assay sectoring, colonies were viewed using a
low-power dissecting microscope. A minimum of 200 col-
onies were analyzed for each plasmid tested at each tem-
perature.
Analysis of relative protein concentrations
To analyze versions of full-length Boi1, boi1 strain Y1284
was used, selecting for plasmids in SC-Ura. To analyze ver-
sions of Boi1-PH, strain PY967 was used, selecting for
plasmids in SC-Ura-Leu. Cultures were grown to an
O.D.600 of 0.8 at 23°C and then diluted 1:1 with 0.4 M
NaOH + 1.7% 2-mercaptoethanol. The resulting lysed-cell
suspensions were then incubated on ice for 10 min, and
protein was made to precipitate using 10% trichloroacetic
acid. Pellets were rinsed first with 70% ethanol and then
with acetone, and they were then suspended in 1% SDS +
3 M urea. Protein concentrations were determined using
the BCA Protein Assay (Pierce, Rockford, IL). 10 µg of to-
tal protein from each sample was subjected to SDS-PAGE
through a 12% gel. Proteins were transblotted to Immo-
bilon P membrane, blots were probed with antibody AP-
101, and bound antibodies were detected by ECL. Each of
the analyses of protein concentration was performed three
times, with similar results.
Localization studies
Yeast strain Y1300 was used for localization studies. Cells
were grown in SC-Ura to select for plasmids that encode
the GFP fusions. Aliquots of cells from exponentially
growing cultures were placed directly (without centrifuga-
tion) onto glass slides for analysis using a Zeiss Axioplan
epifluorescence microscope. No slide sample was ana-
lyzed for longer than 5 min, to avoid stressing the cells.
Quantification of the different localization patterns was
done separately for each morphological category (i.e., an-
alyzing first only unbudded cells, then only small-budded
cells, and then only large-budded cells). Cells in which the
diameter of the bud was less than 1/4 of the diameter of
the mother part of the cell were classified as small-buddedBMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/16
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cells. For each experiment, we analyzed at least 100 cells
in each morphological category, scoring only cells that
gave detectable green fluorescence. Figure 8 shows the av-
erage values from the results of three such experiments. In
some large-budded cells, but in no case more than in 3%
of such cells, green fluorescence was seen both at the neck
and at the mother periphery. Such cells were placed in the
"neck" rather than in the "peripheral" category. Images
were captured using a MicroMAX digital camera system
and WinView/32 software (Princeton Instruments Inc.,
Trenton, N.J.). Images were processed using Photoshop 5
software (Adobe Systems Inc., San Jose, CA).
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